IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.610
+0.010 (0.63%)
Feb 20, 2026, 11:51 AM EST - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $15.72 million as of February 20, 2026. Its market cap has decreased by -14.53% in one year.
Market Cap
15.72M
Enterprise Value
7.89M
1-Year Change
-14.53%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $15.72M, a decrease of -91.62%. That is a compound annual growth rate of -41.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 15.63M | 58.30% |
| Dec 31, 2025 | 9.87M | -47.05% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 16.89M |
| FibroBiologics | 16.71M |
| Hoth Therapeutics | 16.60M |
| Intensity Therapeutics | 16.52M |
| CASI Pharmaceuticals | 16.44M |
| Lexaria Bioscience | 16.42M |
| Curis | 15.61M |
| Citius Pharmaceuticals | 15.46M |